Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: A mendelian randomization study

Diabetes

Volumn 63, Issue 6, 2014, Pages 2114-2119

  Soave, David ^a,b   Miller, Melissa R ^a   Keenan, Katherine ^a   Li, Weili ^a,b   Gong, Jiafen ^a   Ip, Wan ^a   Accurso, Frank ^c   Sun, Lei ^b   Rommens, Johanna M ^a,d   Sontag, Marci ^e   Durie, Peter R ^a,b   Strug, Lisa J ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

ACINAR CELL; ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; OBSERVATIONAL STUDY; PANCREAS DISEASE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

BIOLOGICAL MARKERS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALABSORPTION SYNDROMES; MALE; MENDELIAN RANDOMIZATION ANALYSIS; NEONATAL SCREENING; PANCREAS, EXOCRINE; PANCREATIC DISEASES; PREDICTIVE VALUE OF TESTS;

EID: 84901341005     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1464     Document Type: Article

References (29)

1. Waters DL, Dorney SF, Gaskin KJ, Gruca MA, O'Halloran M, Wilcken B. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. N Engl J Med 1990;322:303-308
2. Durie PR, Forstner GG, Gaskin KJ, et al. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res 1986;20:209-213
3. Ahmed N, Corey M, Forstner G, et al. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003;52:1159-1164
4. Lebenthal E, Lee PC. Development of functional responses in human exocrine pancreas. Pediatrics 1980;66:556-560
5. Imrie JR, Fagan DG, Sturgess JM. Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol 1979;95:697-708
6. Oppenhelmer EH, Esterley Jr. Pathology of cystic fibrosis: review of the literature and comparison with 146 autopsied cases. In Perspectives in Pediatric Pathology. 2nd ed. Rosenberg HS, Bolande RP, Eds. Chicago, Year Book Medical Publishers, 1976, p. 241-278
7. Iannucci A, Mukai K, Johnson D, Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984;15:278-284
8. Sontag MK, Corey M, Hokanson JE, et al. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening. J Pediatr 2006;149:650-657
9. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosisrelated diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-1631
10. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005;146:681-687 (Pubitemid 40616255)
11. Blackman SM, Commander CW, Watson C, et al. Genetic modifiers of cystic fibrosis-related diabetes. Diabetes 2013;62:3627-3635
12. Li W, Soave D, Miller MR, et al. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities. Hum Genet 2014;133;151-161
13. Wright FA, Strug LJ, Doshi VK, et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 2011;43:539-546
14. Chang MH, Plata C, Sindic A, et al. Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain. J Biol Chem 2009;284:28306-28318
15. Bertrand CA, Zhang R, Pilewski JM, Frizzell RA. SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J Gen Physiol 2009;133:421-438
16. Lohi H, Kujala M, Makela S, et al. Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. J Biol Chem 2002;277: 14246-14254 (Pubitemid 34968039)
17. Chang MH, Plata C, Zandi-Nejad K, et al. Slc26a9 - anion exchanger, channel and Na+ transporter. J Membr Biol 2009;228:125-140
18. Didelez V, Meng S, Sheehan NA. Assumptions of IV Methods for Observational Epidemiology. Stat Sci 2010;25:22-40
19. Couper RT, Corey M, Durie PR, Forstner GG, Moore DJ. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic- sufficient patients with cystic fibrosis. J Pediatr 1995;127:408-413
20. Sun L, Rommens JM, Corvol H, et al. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet 2012;44:562-569
21. Vaida F, Liu L. Fast Implementation for Normal Mixed Effects Models With Censored Response. J Comput Graph Stat 2009;18:797-817
22. R Core Development Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2013. Available from http://www.R-project.org/. Accessed 21 February 2014
23. Angrist JD, Krueger AB. The Effect of Age at School Entry on Educational Attainment: An Application of Instrumental Variables with Moments from Two Samples. J Am Stat Assoc 1992;87:328-336
24. Thomas DC, Lawlor DA, Thompson Jr. Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. Ann Epidemiol 2007;17:511-513
25. Rahier J, Wallon J, Henquin JC. Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia 1981;20:540-546 (Pubitemid 11096949)
26. Walkowiak J, Sands D, Nowakowska A, et al. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr 2005;40:199-201 (Pubitemid 40269742)
27. Abu-El-Haija M, Ramachandran S, Meyerholz DK, et al. Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways. Am J Pathol 2012;181:499-507
28. Olivier AK, Yi Y, Sun X, et al. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest 2012;122:3755-3768
29. Koch C, Rainisio M, Madessani U, et al.; Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32:343-350